002382.SZ
蓝帆医疗
SZSE · Healthcare · C 制造业 · CN
CNY 5.90
+0.17%Year over year
Reported trailing growth
- Revenue
- -7.7%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +72.9%
- Operating cash flow
- -19.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.4%
- EBITDA
- —
- EBIT
- -37.5%
- Net income
- -70.3%
- EPS
- -72.7%
- Free cash flow
- +85.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026